Joanna T. Brougher,Founder & Principal,BioPharma Law Group,PLLC to Speak at TKG's Speaking Opportunity-The BPCIA Patent Dance: Recent Trends, Developments and Court Decisions

Top Quote This event is scheduled for August 9, 2017 from 3:00pm–5:00pm(ET). End Quote
  • (1888PressRelease) July 24, 2017 - The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Joanna T. Brougher, Founder & Principal, BioPharma Law Group, PLLC will speak at the Knowledge Group’s webcast entitled: “The BPCIA Patent Dance: Recent Trends, Developments and Court Decisions.”

    For further details, please visit:
    https://theknowledgegroup.org/event-homepage/?event_id=2844

    About Joanna T. Brougher
    Joanna is the Owner and Principal of BioPharma Law Group, PLLC. She is a patent attorney who focuses her practice on all aspects of services related to patents in the life sciences. Joanna has experience counseling clients on the Hatch-Waxman Act and is monitoring developments involving biosimilars under the Biologics Price Competition and Innovation Act. Joanna is also a former Adjunct Lecturer at the Harvard T.H. Chan School of Public Health and the current Editor-in-Chief of the Journal of Commercial Biotechnology. She regularly speaks or lectures on intellectual property-related topics and is a frequent author of articles related to patent law and healthcare. In 2013, Joanna published a book called Intellectual Property and Health Technologies: Balancing Innovation and the Public's Health which examines the relationship between patents and public health in the context of medical technologies. In 2014, Joanna was selected to the National Law Journal’s list of Boston’s Rising Stars. Joanna received her J.D. degree from Boston College Law School, and is admitted to the Massachusetts and New York State Bars as well as the USPTO.

    About BioPharma Law Group, PLLC
    BioPharma Law Group, PLLC is a law firm that serves life sciences companies, including biotechnology, pharmaceutical, and medical device companies, at all stages. We provide efficient, focused, and practical legal advice and solutions to enable life science companies to meet their intellectual property and corporate goals and needs.

    We represent life sciences companies, with a focus on the biotechnology, pharmaceutical, and medical device sectors. Our list of clients includes innovator and generic/biosimilar companies, sponsor companies and manufacturers, start-ups and mid-stage companies, public and private companies, universities, investors, as well as individual entrepreneurs, scientists, engineers, and physicians.

    Event Synopsis:
    In Sandoz Inc. v. Amgen Inc. decision, the Supreme Court provided some clarity in the “patent dance” issues under the Biologics Price Competition and Innovation Act (BPCIA). The court unanimously ruled that a biosimilar applicant cannot be enjoined by a biologic sponsor for declining to provide a copy of its application and manufacturing information; and that a biosimilar applicant is permitted to provide 180-day premarketing notice either before or after obtaining FDA approval. While the decision provided the biosimilar industry with a potential boost, it is still important for the members of patent, healthcare and pharmaceutical sectors to remain updated with the recent regulatory trends and developments to effectively grapple with the potential issues, implications and risks.

    In this LIVE Webcast, a panel of distinguished professionals and thought leaders organized by The Knowledge Group will provide the audience with an in-depth discussion of the fundamentals as well as updates regarding the latest and significant issues surrounding the BPCIA Patent Dance. Speakers will also offer practical litigation strategies and best compliance practices.

    Some of the major topics that will be covered in this course are:
    -The BPCIA Patent Dance – An Overview
    -Recent Court Decisions
    -Emerging Trends and Regulatory Developments
    -Challenges, Issues and Implications
    -Key Takeaways
    -Litigation Tips and Strategies
    -Best Compliance Practices

    About The Knowledge Group/The Knowledge Congress Live Webcast Series
    The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information